Showing results (11-20 of 19) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Current Pharmaceutical Design|February 14, 2006
The cell cycle and hormonal fluxes in Alzheimer disease: a novel therapeutic targetKate M Webber, Gemma Casadesus, Xiongwei Zhu, et al.Journal of Biomedicine & Biotechnology|October 19, 2006
Targeting gonadotropins: an alternative option for Alzheimer disease treatmentGemma Casadesus, Emma Ramiro Puig, Kate M Webber, et al.Drugs in R&D|June 7, 2006
The estrogen myth: potential use of gonadotropin-releasing hormone agonists for the treatment of Alzheimer's diseaseGemma Casadesus, Matthew R Garrett, Kate M Webber, et al.Annals of the New York Academy of Sciences|July 19, 2005
Estrogen bows to a new master: the role of gonadotropins in Alzheimer pathogenesisKate M Webber, Gemma Casadesus, Michael W Marlatt, et al.Current Medicinal Chemistry|May 17, 2005
Therapeutic opportunities in Alzheimer disease: one for all or all for one?Michael W Marlatt, Kate M Webber, Paula I Moreira, et al.Mechanisms of Ageing and Development|June 7, 2005
The cell cycle in Alzheimer disease: a unique target for neuropharmacologyKate M Webber, Arun K Raina, Michael W Marlatt, et al.Molecular and Cellular Endocrinology|March 23, 2007
Increases in luteinizing hormone are associated with declines in cognitive performanceGemma Casadesus, Erin L Milliken, Kate M Webber, et al.Molecular Neurodegeneration|October 5, 2006
Steroidogenic acute regulatory protein (StAR): evidence of gonadotropin-induced steroidogenesis in Alzheimer diseaseKate M Webber, Douglas M Stocco, Gemma Casadesus, et al.International Journal of Clinical and Experimental Pathology|September 12, 2008
Retinoblastoma protein phosphorylation at multiple sites is associated with neurofibrillary pathology in Alzheimer diseaseAkanksha Thakur, Sandra L Siedlak, Sheronica L James, et al.Pageof 2